Consistent with the findings of Takashima et al., in the retrospective study by Willis et al. evaluating three different cohorts of ovarian cancer samples (see above part 4), the SLFN11 expression was generally low in serous carcinoma with a median H-score of 20. Here, SLFN11 is linked to serous adenocarcinoma.